Pfizer announced Monday it has begun the next phases of testing for its covid-19 oral antiviral drug to limit infection in those who have been exposed.
Greg Heilman
Pfizer announced Monday it has begun the next phases of testing for its covid-19 oral antiviral drug to limit infection in those who have been exposed.
